OasisLMS

This course discusses a novel approach for administering pediatric chemotherapy infusions in outpatient examination rooms. It outlines objectives for healthcare professionals, including the safe administration of three chemotherapy agents in an ambulatory setting, the impact of alternative infusion locations on appointment itineraries, and the overall effect on pediatric hematology/oncology families. Additionally, it includes questions related to process improvements, patient capacity during the COVID-19 pandemic, and metrics for evaluating the success of the pilot project.

• Describe 3 chemotherapy agents which can be safely administered in an ambulatory clinic setting. 
• Explain how an alternative infusion location can be used for short infusions in the pediatric setting. 
• Describe how shorter appointment itineraries can impact pediatric hematology/oncology families.

APHON will provide 1 nursing continuing professional development (NCPD) contact hour(s) for the successful completion of this course. Successful completion of:

1. JOPHON Article Review
2. Post-Test
3. Evaluation

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. You may claim 1 NCPD in one of the following ILNA categories: Care Continuum, Psychosocial Dimensions of Care, OR Care of the Pediatric Hem/Onc Patient 

The Association for Pediatric Hematology Oncology Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This provider is also approved by the California Board of Registered Nursing, Provider Number 14513.

None of the planners for this activity have relevant financial relationship(s) to disclose with ineligible companies.

Questions or concerns? Contact education@aphon.org.